XENON XE 127

LOE Approaching

xenon xe-127

NDAINHALATIONGAS

Approved

Oct 1982

Lifecycle

LOE Approaching

Competitive Pressure

30/100

Data completeness

1/8 — Limited

XENON XE-127 is an inhaled xenon gas approved since 1982 for diagnostic and/or therapeutic applications. The exact clinical indication is not specified in available data, but xenon gas products are typically used for imaging or anesthesia purposes. Its mechanism of action and pharmacologic class remain undocumented in this dataset.

LOE Approaching

With LOE approaching and minimal linked job activity, this product faces commercial headwinds and likely operates as a niche, mature brand with a small or consolidating team.

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Career Relevance

This product currently shows zero linked job openings, indicating minimal active hiring and likely a small, stable team. Joining this asset offers niche expertise in mature gas-phase therapeutics but limited career acceleration opportunities.

External Resources

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.